CliffBio
small molecule

CALCIBIND

CELLULOSE SODIUM PHOSPHATE

Loss of exclusivity—loss of exclusivity
CompanyMISSION PHARMACAL CO

Drug detail

Brand nameCALCIBIND
Active ingredientCELLULOSE SODIUM PHOSPHATE
Strength2.5GM/PACKET
Dosage formPOWDER
RouteORAL
ModalitySmall molecule
FDA approvalDecember 1982
Marketing statusDISCN

More from MISSION PHARMACAL CO

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CALCIBIND patent cliff — loss of exclusivity — | CliffBio